James M. Hoffman is the Chief Patient Safety Officer and an Associate Member in Pharmaceutical Sciences at St. Jude Children’s Research Hospital in Memphis, Tennessee. He provides oversight and leadership for patient safety across St. Jude, which is a hospital focused on research and treatment for children with catastrophic diseases. He focuses on refining existing tools and identifying new means of patient safety event detection, assessing and improving patient safety culture, and developing and improving clinical decision support. At St. Jude, he has been involved in efforts related to all of these areas, and has extensive experience leading change across St. Jude. Dr. Hoffman was a core member of the team that recently created St. Jude’s new strategic plan for Quality and Patient Care.
Through work at St. Jude (PG4KDS www.stjude.org/pg4kds) and internationally through the Clinical Pharmacogenetic Implementation Consortium (CPIC https://cpicpgx.org), Dr. Hoffman is devoted to implementing pharmacogenetics as a patient safety strategy. He hopes to accelerate the implementation of research discoveries in pharmacogenomics into the clinic through the development and dissemination of model practices and clinical practice guidelines. He has experience developing and refining clinical decision support for pharmacogenomics in electronic health records, which informs his leadership of the CPIC Informatics group with colleagues from Mayo Clinic and Stanford University.
Dr. Hoffman has served the Section of Pharmacy Practice Managers (now Section of Pharmacy Practice Leaders) in a variety of capacities, including Vice Chair and Chair of the Section Advisory Group on Quality and Compliance, Director at Large and Chair of the Section Executive Committee. He has also served ASHP through service on the Council on Pharmacy Practice, the FASHP Recognition Committee, and in the House of Delegates. He continues to develop resources to support pharmacy practice leaders through contributions to the ASHP Foundation Pharmacy Forecast as a steering committee member and as an author on the annual prescription drug expenditure forecast published in AJHP.